EUVIMEDEUVIMED entdecken
Open Access

A Diagnostic Dilemma: New Enhancing Suspicious Findings on Breast MRI Following Neoadjuvant Chemotherapy

Jennifer R LaRoy, Audree B Tadros, Varadan Sevilimedu, Victoria L Mango iD

Journal of Breast Imaging · 2023

DOI: 10.1093/jbi/wbad035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Breast Imaging, 2023. Verfasst von Jennifer R LaRoy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Memorial Sloan Kettering Cancer Center, Department of Radiology, New York, NY, USA. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, P30 Cancer Center Support Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Evaluate the incidence and outcome of new enhancing findings on breast MRI after neoadjuvant chemotherapy (NAC).

Methods

This IRB-approved retrospective review included women with breast cancer undergoing MRI to evaluate NAC response at our institution from January 1, 1998 to March 3, 2021. Post-NAC MRIs given BI-RADS 4 or 5 with new enhancing findings were identified. Patients were excluded if they lacked pretreatment MRI or insufficient follow-up, or if the finding was a satellite of the primary tumor. Medical records and imaging studies were reviewed to identify patients and to find characteristics and outcomes.

Results

Over the study period, 2880 post-NAC breast MRIs were performed. Of 128 post-NAC MRIs given BI-RADS 4 or 5 (4.4%), 35 new suspicious findings were found on 32 MRIs, incidence rate 1.1% (32/2880). Most were characterized as nonmass enhancement (17/35, 49%), followed by mass (11/35, 31%), and then focus (7/35, 20%), with an average maximum dimension of 1.3 cm (range 0.3–7.1 cm). New findings were ipsilateral to the index cancer in 20/35 (57%) of cases. Of the 35 suspicious findings, 22 underwent image-guided biopsy (62%), 1 was surgically excised (3%), 7 underwent mastectomy (20%), 5 were stable or resolved on follow-up (8%), and none were malignant. Thirty-three were benign (94%), and two were benign high-risk lesions (atypical ductal hyperplasia, radial scar) (6%).

Conclusion

New suspicious breast MRI findings after NAC are uncommon with a low likelihood of malignancy. Further study is warranted using multi-institutional data for this low incidence finding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsFemaleHumansBreastMagnetic Resonance ImagingMastectomyNeoadjuvant TherapyRetrospective Studies

Stichwörter der Autor:innen

breast MRIbreast cancerneoadjuvant chemotherapy

Autor:innen und Institutionen

  • Memorial Sloan Kettering Cancer Center, Department of Radiology, New York, NY, USA.
  • Memorial Sloan Kettering Cancer Center, Department of Surgery, New York, NY, USA.
  • Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics, New York, NY, USA.

ORCID-Profile: Victoria L Mango

Förderung

  • NCI NIH HHS
  • P30 Cancer Center Support Grant

Zitieren

APA

LaRoy, J. R., Tadros, A. B., Sevilimedu, V., & Mango, V. L. (2023). A Diagnostic Dilemma: New Enhancing Suspicious Findings on Breast MRI Following Neoadjuvant Chemotherapy. Journal of Breast Imaging. https://doi.org/10.1093/jbi/wbad035

Vancouver

LaRoy JR, Tadros AB, Sevilimedu V, Mango VL. A Diagnostic Dilemma: New Enhancing Suspicious Findings on Breast MRI Following Neoadjuvant Chemotherapy. Journal of Breast Imaging. 2023. doi:10.1093/jbi/wbad035

BibTeX
@article{LaRoy2023,
  author = {LaRoy, Jennifer R and Tadros, Audree B and Sevilimedu, Varadan and Mango, Victoria L},
  title = {A Diagnostic Dilemma: New Enhancing Suspicious Findings on Breast MRI Following Neoadjuvant Chemotherapy},
  journal = {Journal of Breast Imaging},
  year = {2023},
  doi = {10.1093/jbi/wbad035}
}
Kostenlos starten →